William Gaarde
15Patents
9h-index
15Co-inventors
65Inventor score
Filing activity: Aug 7, 1998 → Jan 28, 2008
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US6133246A | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins | Chemistry; Metallurgy | 140 | Expired |
| US6965025B2 | Antisense modulation of connective tissue growth factor expression | Emerging Cross-Sectional Technologies | 134 | Expired |
| US7709630B2 | Antisense modulation of connective tissue growth factor expression | Emerging Cross-Sectional Technologies | 123 | Active |
| US6287860A | Antisense inhibition of MEKK2 expression | Emerging Cross-Sectional Technologies | 103 | Expired |
| US6133031A | Antisense inhibition of focal adhesion kinase expression | Chemistry; Metallurgy | 38 | Expired |
| US6809193B2 | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins | Chemistry; Metallurgy | 23 | Expired |
| US6221850A | Antisense oligonucleotide compositions and methods for the modulation of JNK proteins | Chemistry; Metallurgy | 16 | Expired |
| US6331399A | Antisense inhibition of tert expression | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6448079B1 | Antisense modulation of p38 mitogen activated protein kinase expression | Emerging Cross-Sectional Technologies | 14 | Expired |
| US6168950A | Antisense modulation of MEKK1 expression | Emerging Cross-Sectional Technologies | 9 | Expired |
| US6140124A | Antisense modulation of P38 mitogen activated protein kinase expression | Emerging Cross-Sectional Technologies | 5 | Expired |
| US7507810B2 | Compositions and their uses directed to IL-4R alpha | Chemistry; Metallurgy | 5 | Active |
| US6492171B2 | Antisense modulation of TERT expression | Emerging Cross-Sectional Technologies | 2 | Expired |
| US8076306B2 | Compositions and their uses directed to hepcidin | Chemistry; Metallurgy | 1 | Active |
| US6080546A | Antisense modulation of MEKK5 expression | Emerging Cross-Sectional Technologies | 1 | Expired |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.